Subsequent IHC imaging of CD31 showed that both EVT801 and pazopanib marginally decreased the amount of vessels within the tumor; nevertheless, the remaining vessels in the tumor were significantly larger upon EVT801 treatment than upon pazopanib treatment (Fig. 3I and J). The gene discussed is PECAM1; the disease is neoplasm.